S33 Update on Genomics in Pediatric Endocrinology

Program: Symposia
Clinical/Translational Session
Saturday, April 2, 2016: 8:15 AM-9:45 AM
BR East (BCEC)
Chair:
Sally Radovick, MD, Johns Hopkins School of Medicine, Baltimore, MD

Nothing to Disclose: SR
8:15 AM
Mehul Tulsidas Dattani, MBBS MD DCH FRCP FRCPCH, Genetics & Genomic Medicine Programme, UCL Institute of Child Health, London, United Kingdom
Disclosures:
MTD: Teacher, Novo Nordisk, Advisory Group Member, Sandoz, Teacher, Ferring Pharmaceuticals.
9:15 AM
Rajesh V Thakker, FRS, FMedSci, FRCPath, FRCPE, FRCP, Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom
Nothing to Disclose: RVT
See more of: Symposia

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire